AIP
AVNR

Ameritas Investment Partners’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Ameritas Investment Partners’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-17,005
Closed -$288K – 1249
2014
Q4 		$288K Buy
17,005
+1,894
+13% +$26.6K 0.02% 837
2014
Q3 		$180K Buy
15,111
+789
+6% +$5.39K 0.01% 971
2014
Q2 		$81K Buy
14,322
+1,485
+12% +$6.84K 0.01% 1051
2014
Q1 		$47K Hold
12,837
– – ﹤0.01% 1047
2013
Q4 		$43K Hold
12,837
– – ﹤0.01% 1042
2013
Q3 		$54K Buy
+12,837
New +$60.8K 0.01% 984

Ameritas Investment Partners's AVNR Position: Q1 2015 in Review

Ameritas Investment Partners sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 17,005 shares — an estimated $288K sold.

Ameritas Investment Partners first reported a position in AVNR in Q3 2013 and held it in 6 quarters. The position peaked at $288K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Ameritas Investment Partners reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Ameritas Investment Partners sold 17,005 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $288K.
  • Ameritas Investment Partners first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 6 quarters.
  • Ameritas Investment Partners's AVANIR PHARMACEUTICALS, INC CL A position peaked at $288K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Ameritas Investment Partners's 13F filing for Q1 2015, filed 14 May 2015.